May 27, 2022

Volume XII, Number 147

Advertisement
Advertisement

May 27, 2022

Subscribe to Latest Legal News and Analysis

May 26, 2022

Subscribe to Latest Legal News and Analysis

May 25, 2022

Subscribe to Latest Legal News and Analysis

May 24, 2022

Subscribe to Latest Legal News and Analysis

Podcast: President Biden’s Use of the Defense Production Act – Diagnosing Health Care

New from the Diagnosing Health Care Podcast:  The Biden administration has invoked the Defense Production Act (“DPA”) to speed up the production of vaccines and increase the domestic production of COVID-19 tests, personal protective equipment (or “PPE”), and other essential supplies. Epstein Becker Green attorneys Neil Di SpiritoConstance Wilkinson, and Bonnie Odom discuss the administration’s reliance on the DPA as it continues to operationalize its pandemic response, and the challenges these actions are likely to present for medical product suppliers.

For more, listen to our previous episodes relating to vaccination and supply chain issues:

The Diagnosing Health Care podcast series examines the business opportunities and solutions that exist despite the high-stakes legal, policy, and regulatory issues that the health care industry faces. Subscribe on your favorite podcast platform.

 

Listen on Apple Podcasts, Google Podcasts,
Overcast, Spotify, Stitcher, YouTube, and Vimeo.

 

©2022 Epstein Becker & Green, P.C. All rights reserved.National Law Review, Volume XI, Number 84
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement

About this Author

Neil Di Spirito, Epstein Becker Law Firm, Washington DC and St Petersburg, Healthcare Law Attorney
Member

NEIL P. DI SPIRITO* is a Member of the Firm in the Health Care and Life Sciences practice, in the Washington, DC, and the St. Petersburg offices of Epstein Becker Green. He has more than two decades of experience helping pharmaceutical, medical device, biologic, and life sciences clients comply with U.S. and international drug, biologic, and medical product regulation.

Mr. Di Spirito:

  • Provides regulatory and enforcement counsel to companies of all sizes on products regulated by...

202-861-5333
Constance A. Wilkinson, Epstein Becker, Life Sciences Litigation Lawyer, Health Audits Attorney, Due Diligence
Member

CONSTANCE A. WILKINSON is a Member of the Firm in the Litigation and Health Care and Life Sciences Practices in the firm's Washington, DC office, with a primary focus on federal health care contracting.

Ms. Wilkinson:

  • Conducts due diligence and internal investigations and audits and responding to criminal fraud and abuse investigations

  • Analyzes cost allowability and pricing issues for proposals or audits

  • Develops...

202-861-1378
Bonnie Odom Health Care Attorney Epstein Becker & Green Washington, DC
Member of the Firm

Bonnie Odom is an Associate in the Health Care and Life Sciences practice, in the firm's Los Angeles and Washington, DC, offices.

Ms. Odom's experience includes:

  • Conducting health regulatory due diligence for transactions involving life sciences companies
  • Providing advice to pharmaceutical and device manufacturers on U.S. Food and Drug Administration ("FDA") compliance matters, including FDA premarket clearance and approval strategies and advertising and promotion issues
  • Advising mobile app companies and other new entrants to the FDA-...
202-861-1869
Advertisement
Advertisement
Advertisement